Theriva Biologics
TOVX
TOVX
56 hedge funds and large institutions have $75.5M invested in Theriva Biologics in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 5 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Holders
56
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$831K | |
| 2 | +$660K | |
| 3 | +$536K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$432K |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$313K |
Top Sellers
| 1 | -$801K | |
| 2 | -$362K | |
| 3 | -$298K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$220K |
| 5 |
BCM
Bluefin Capital Management
New York
|
-$112K |